Telomerase is a specialized ribonucleoprotein complex that extends the 3= ends of chromosomes to counteract telomere shortening. However, increased telomerase activity is associated with ϳ90% of human cancers. The telomerase enzyme minimally requires an RNA (hTR) and a specialized reverse transcriptase protein (TERT) for activity in vitro. Understanding the structurefunction relationships within hTR has important implications for human disease. For the first time, we have tested the physicalconnectivity requirements in the 451-nucleotide hTR RNA using circular permutations, which reposition the 5= and 3= ends. Our extensive in vitro analysis identified three classes of hTR circular permutants with altered function. First, circularly permuting 3= of the template causes specific defects in repeat-addition processivity, revealing that the template recognition element found in ciliates is conserved in human telomerase RNA. Second, seven circular permutations residing within the catalytically important core and CR4/5 domains completely abolish telomerase activity, unveiling mechanistically critical portions of these domains. Third, several circular permutations between the core and CR4/5 significantly increase telomerase activity. Our extensive circular permutation results provide insights into the architecture and coordination of human telomerase RNA and highlight where the RNA could be targeted for the development of antiaging and anticancer therapeutics.
Linear eukaryotic chromosomes terminate in repeated DNA sequences, called telomeres, which are bound by specific proteins to protect the ends from degradation and detrimental end joining. However, these termini present an end-replication problem that most eukaryotes overcome by utilizing the ribonucleoprotein (RNP) complex telomerase. Telomerase comprises an RNA (hTR in humans) and a reverse transcriptase (TERT), which catalyzes telomere addition. It has been shown that telomeres shorten with aging, and telomerase upregulation occurs in ϳ90% of human cancers (1). Furthermore, mutations in telomerase components have been linked to a variety of short-telomere syndromes, such as dyskeratosis congenita, pulmonary fibrosis, and aplastic anemia (2). Thus, understanding the structure-function relationships of human telomerase RNA is crucial to combat a range of human ailments.During the telomerase catalytic cycle, a short region of the telomerase RNA, known as the template, pairs with the laggingstrand telomeric 3= overhang. The template is then used to direct the iterative addition of the telomeric repeats (TTAGGG in humans), catalyzed by an active site within the TERT protein. Once TERT reaches the end of the RNA template, the DNA substrate is realigned so that additional repeats can be added (3). This ability of the RNA-protein enzyme complex to translocate underlies the enzyme's repeat-addition processivity (RAP). In addition to hTR and TERT, additional accessory proteins bind telomerase in vivo (4). Many studies have been done to identify important regions within hT...